Peña-Solórzano Diana, Scholler Matthias, Bernhardt Günther, Buschauer Armin, König Burkhard, Ochoa-Puentes Cristian
Laboratorio de Síntesis Orgánica Sostenible, Departamento de Química, Universidad Nacional de Colombia-Sede Bogotá, 5997 Bogotá, Colombia.
Institute of Organic Chemistry and Institute of Pharmacy, University of Regensburg, D-93040 Regensburg, Germany.
ACS Med Chem Lett. 2018 Jul 25;9(8):854-859. doi: 10.1021/acsmedchemlett.8b00289. eCollection 2018 Aug 9.
ABC transporters, including ABCG2, play a vital role in defending the human body against the vast range of xenobiotics. Even though this is beneficial for human health, these protein transporters have been implicated in the emerging resistance of cancer cells to a variety of structurally and functionally diverse anticancer drugs. In order to investigate their role in resistance, potent and selective ABCG2 modulators have been described in the literature. A leading class of modulators are the tariquidar analogues; however, their susceptibility to hydrolysis limits their applicable use. To overcome this, we synthesized a novel series of chalcone- and ketone-based compounds inspired by reported tariquidar analogues. Compounds were characterized and evaluated for their ABCG2 modulatory activity and ABC transporter selectivity. When compared to transporters ABCB1 and ABCC1, the chalcone-based compounds exhibited selectivity for ABCG2, while the ketone-based compounds showed only a slight preference for ABCG2. From the former series, chalcone (UR-DP48) displayed similar activity to the reference fumitremorgin C, both producing comparable maximal effects. The compound exhibited marked antiproliferative activity, while cytotoxicity was less pronounced for the most active compound from the ketone series. Chalcone-containing tariquidar analogues are promising modulators to aid in functional investigations of ABCG2 transporters.
包括ABCG2在内的ABC转运蛋白在保护人体免受大量外源性物质侵害方面发挥着至关重要的作用。尽管这对人类健康有益,但这些蛋白质转运体与癌细胞对多种结构和功能各异的抗癌药物产生的新耐药性有关。为了研究它们在耐药性中的作用,文献中已描述了强效且选择性的ABCG2调节剂。一类主要的调节剂是 tariquidar类似物;然而,它们对水解的敏感性限制了其应用。为克服这一问题,我们受已报道的tariquidar类似物启发,合成了一系列新型的查尔酮和酮基化合物。对这些化合物进行了表征,并评估了它们的ABCG2调节活性和ABC转运体选择性。与转运蛋白ABCB1和ABCC1相比,基于查尔酮的化合物对ABCG2具有选择性,而基于酮的化合物仅对ABCG2表现出轻微偏好。在前一系列化合物中,查尔酮(UR-DP48)显示出与参考药物烟曲霉毒素C相似的活性,两者产生的最大效应相当。该化合物表现出显著的抗增殖活性,但酮系列中最具活性的化合物的细胞毒性则不太明显。含查尔酮的tariquidar类似物是有助于ABCG2转运体功能研究的有前景的调节剂。